Jin Ho Baek - Concepedia

Author

Jin Ho Baek

Kyungpook National University Hospital ORCID

Also Known As

J H Baek, J. Baek, J. H. Baek, J.H Baek, J.H. Baek, JIN HO BAEK, JIn Ho Baek, Ji Hoon Baek, Jin Baek, Jin H Baek

147

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Kyungpook National University Hospital Ulsan University Hospital University of Ulsan Ulsan College Keimyung University

About

Jin Ho Baek is an author at Kyungpook National University Hospital specializing in medicine, immunology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	26	870
2	Cell Biology	9	9	228
3	Health Sciences	5	5	188
4	Blood Transplantation	3	3	89
5	Public Health	1	1	25

Jin Ho Baek

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer Jia-Lin Lee, Y-K. Kang, Hye Jin Kang, British Journal of Cancer	2008	136
Protective role of interleukin-10 promoter gene polymorphism in the pathogenesis of invasive pulmonary aspergillosis after allogeneic stem cell transplantation K W Seo, D H Kim, Sang Kyun Sohn, Bone Marrow Transplantation InflammationTransplantationMedicineImmunologyPathology	2005	101
Efficacy of EGFR tyrosine kinase inhibitors in patients with EGFR-mutated non-small cell lung cancer except both exon 19 deletion and exon 21 L858R: A retrospective analysis in Korea Jin Ho Baek, Jong‐Mu Sun, Young Joo Min, Lung Cancer MedicineRetrospective AnalysisPathologyBronchial NeoplasmCancer Treatment	2014	86
Multidrug resistance‐1 gene polymorphisms associated with treatment outcomes in <i>de novo</i> acute myeloid leukemia Dong Hwan Kim, Jae Yong Park, Sang Kyun Sohn, International Journal of Cancer	2005	77
Clinical Implications of Claudin18.2 Expression in Patients With Gastric Cancer Jin Ho Baek, Dong Jin Park, Gyu Yeol Kim, Anticancer Research	2019	77
Targeting c-KIT (CD117) by dasatinib and radotinib promotes acute myeloid leukemia cell death Sook‐Kyoung Heo, Eui‐Kyu Noh, Jeong Yi Kim, Scientific Reports Hematological MalignancyTumor BiologyChronic Myeloid LeukemiaMedicineApoptosis	2017	67
Clinical implications of angiogenic factors in patients with acute or chronic leukemia: Hepatocyte growth factor levels have prognostic impact, especially in patients with acute myeloid leukemia Jong Gwang Kim, Sang Kyun Sohn, Dong Hwan Kim, Leukemia & lymphoma/Leukemia and lymphoma Mixed-phenotype Acute LeukemiaImmunologyPathologyAngiogenic FactorsTumor Biology	2005	62
CHOP plus etoposide and gemcitabine (CHOP-EG) as front-line chemotherapy for patients with peripheral T cell lymphomas Jong Gwang Kim, Sang Kyun Sohn, Yee Soo Chae, Cancer Chemotherapy and Pharmacology Lymphoid NeoplasiaMedicineImmunologyHematologyFront-line Chemotherapy	2005	61
Transplantation with higher dose of natural killer cells associated with better outcomes in terms of non‐relapse mortality and infectious events after allogeneic peripheral blood stem cell transplantation from HLA‐matched sibling donors Dong Hwan Kim, Sang Kyun Sohn, Nan Young Lee, European Journal Of Haematology	2005	47
IL-10 Promoter Gene Polymorphism Associated with the Occurrence of Chronic GVHD and Its Clinical Course During Systemic Immunosuppressive Treatment for Chronic GVHD after Allogeneic Peripheral Blood Stem Cell Transplantation Dong Hwan Kim, Nan Young Lee, Sang Kyun Sohn, Transplantation	2005	45

Page 1